Glyburide Tablet
Product Images NDC 0093-8034

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 0093-8034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyburide Tablet 1

FDA Label Image

Glyburide Tablet 2

FDA Label Image

Glyburide Tablet 3

This is a description of a medication, specifically Glipizide tablets USP in the dosage of 1.5 mg, and with lot number 361-32-734526240. The medication is packaged in a bottle with 100 tablets and the expiration date is not available.*

FDA Label Image

Glyburide Tablet 4

This is a medication bottle of Glyburide tablets with a strength of 3mg. The GTIN number (a type of global product identification code) is visible on the package. The label includes a warning to keep the medication out of the reach of children. The rest of the text seems to be a mix of non-English characters and symbols, making it difficult to make sense of it.*

FDA Label Image

Glyburide Tablet 5

This is a description of a medication named GlyBURIDE, which comes in the form of Tablets USP, with a strength of 6 mg. The medicine is produced by NDC and has a code of 0093-8036-01. The other details provided are the lot number of the tablets, which is 100, and the revision number, which is 06 for Rev. E produced in November 2017.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.